Discover
IRON
Disc Medicine, Inc.
61.30
2 x 56.05
1 x 77.67
bid
ask
-
0.76
1.23%
11:56 AM
timesize
| Ytd | -22.81% | |
| 1y | -12.30% |
60.75
day range
62.76
55.95
52 week range
94.11
| Open | 62.20 | Prev Close | 62.06 | Low | 60.75 | High | 62.76 | Mkt Cap | 2.35B |
| Vol | 93.72K | Avg Vol | 476.91K | EPS | -6.58 | P/E | N/A | Forward P/E | -8.77 |
| Beta | 0.93 | Short Ratio | 14.68 | Inst. Own | 114.11% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-05 | 50-d Avg | 73.54 | 200-d Avg | 71.21 | 1yr Est | 103.17 |
| Income Statement | |||
| Operating Expenses | 65.08M | ||
| Research and Development Expense | 46.93M | ||
| Selling, General and Administrative Expense | 18.14M | ||
| Operating Income | -65.07M | ||
| Interest Expense | 908.00K | ||
| Income Tax Expense | 69.00K | ||
| Net Income | -59.53M | ||
| Net Income Common Stock | -59.53M | ||
| Net Income Common Stock (USD) | -59.53M | ||
| Consolidated Income | -59.53M | ||
| Earnings per Basic Share | -1.54 | ||
| Earnings per Basic Share (USD) | -1.54 | ||
| Earnings per Diluted Share | -1.54 | ||
| Earning Before Interest & Taxes (EBIT) | -58.55M | ||
| Earning Before Interest & Taxes (USD) | -58.55M | ||
| Weighted Average Shares | 38.69M | ||
| Weighted Average Shares Diluted | 38.69M | ||
| Balance Sheet | |||
| Cash and Equivalents | 98.68M | ||
| Cash and Equivalents (USD) | 98.68M | ||
| Investments | 619.07M | ||
| Investments Current | 619.07M | ||
| Current Assets | 732.76M | ||
| Property, Plant & Equipment Net | 1.81M | ||
| Total Assets | 735.07M | ||
| Debt Current | 315.00K | ||
| Total Debt | 60.86M | ||
| Current Liabilities | 30.36M | ||
| Debt Non-Current | 60.55M | ||
| Total Liabilities | 90.91M | ||
| Accumulated Retained Earnings (Deficit) | -633.22M | ||
| Accumulated Other Comprehensive Income | -1.61M | ||
| Shareholders Equity | 644.16M | ||
| Shareholders Equity (USD) | 644.16M | ||
| Assets Non-Current | 2.31M | ||
| Total Debt (USD) | 60.86M | ||
| Liabilities Non-Current | 60.55M | ||
| Trade and Non-Trade Payables | 6.84M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 223.00K | ||
| Net Cash Flow from Financing | 32.34M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 9.76M | ||
| Issuance (Purchase) of Equity Shares | 2.36M | ||
| Issuance (Repayment) of Debt Securities | 29.98M | ||
| Net Cash Flow from Investing | 21.63M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 21.63M | ||
| Net Cash Flow from Operations | -44.20M | ||
| Share Based Compensation | 13.95M | ||